Back to top
more

InterCure (INCR)

(Delayed Data from NSDQ)

$2.66 USD

2.66
11,858

+0.02 (0.76%)

Updated Apr 26, 2024 03:59 PM ET

After-Market: $2.66 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (142 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

InterCure Ltd. [INCR]

Reports for Purchase

Showing records 1 - 20 ( 45 total )

Company: InterCure Ltd.

Industry: Medical - Products

Record: 1

06/27/2022

Industry Report

Pages: 10

Weekly ReHash: California at Inflection on Easing Regulations & Improved Access

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 2

01/04/2018

Daily Note

Pages: 8

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 3

01/04/2018

Daily Note

Pages: 7

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 4

01/03/2018

Company Report

Pages: 3

Anyone Want to Be CFO of INC Research?

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 5

01/02/2018

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for INCR

Provider: ValuEngine, Inc

Price: 25.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 6

12/20/2017

Daily Note

Pages: 4

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 10.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 7

12/20/2017

Daily Note

Pages: 47

Are You Ready for the Future of Healthcare? (2018 Outlook)

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 100.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 8

11/14/2017

Company Report

Pages: 9

Sum of the Parts - We reiterate our OW rating

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 25.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 9

11/13/2017

Daily Note

Pages: 6

Tech Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 10

11/13/2017

Daily Note

Pages: 9

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 11

11/10/2017

Company Report

Pages: 5

Occam''s Razor - We reiterate our Overweight rating

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 12

10/13/2017

Daily Note

Pages: 8

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 13

10/12/2017

Company Report

Pages: 6

The Great Wall of China, No More

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 25.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 14

07/27/2017

Daily Note

Pages: 3

Initial Take on 2Q17 (Immediate Post Conference Call)

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 15

06/12/2017

Company Report

Pages: 8

Busy Little Bees

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 25.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 16

06/05/2017

Daily Note

Pages: 11

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 17

06/04/2017

Company Report

Pages: 13

The More We Look, the More We Like

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 50.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 18

05/25/2017

Daily Note

Pages: 31

Healthcare IT, Biopharmaceutical Services and Laboratories: Post-1Q17 Model Book

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 75.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 19

05/25/2017

Daily Note

Pages: 18

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: InterCure Ltd.

Industry: Medical Services

Record: 20

05/10/2017

Daily Note

Pages: 5

Makes a Big Move by Merging with InVentiv (Initial Take-Aways)

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 10.00

Research Provided by a Third Party